FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

23964811000001100: Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Mar 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
78537401000001115 Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78537501000001116 Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Is a Trastuzumab emtansine 100mg powder for solution for infusion vials true Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient Trastuzumab emtansine false Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Is a Kadcyla true Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has active ingredient Monoclonal antibody true Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient Trastuzumab emtansine true Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has AMP True Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start